MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2025 International Congress

    A Case of Mitochondrial Membraine Protein-Associated Neurodegeneration with Progressive Parkinsonism in a Young Male

    B. Akkineni, L. Teshome, E. Krause (Austin, USA)

    Objective: N/a Background: Less than a hundred cases of mitochondrial membrane protein-associated neurodegeneration (MPAN) have been reported thus far in literature. We present a case…
  • 2025 International Congress

    Diverse clinical phenotypes of ATP1A3 mutations-A case series of four patients

    S. Rath, V. Holla, P. Pal, N. Kamble, R. Yadav (BANGALORE, India)

    Objective: To study the clinical phenotype of all patients with ATP 1A3 mutation in the genetic study Background: ATP1A3 is associated with a broad spectrum…
  • 2025 International Congress

    Stepping backwards to move forward A case study on novel PT interventions for DLB

    K. Vasher, A. Boddy (Loma Linda, USA)

    Objective: Explore the effectiveness of backwards walking and backwards stepping interventions to improve gait stability and balance in persons with Dementia with Lewy Bodies (DLB).…
  • 2025 International Congress

    4R-TAU seed amplification assay discriminates tauopathies from non-tauopathies and CBD from PSP in post-mortem brain samples

    L. de Mena, M. Fernandez, J. Perez, C. Painous, A. Camara, A. Perez-Soriano, L. Molina-Porcel, E. Artikis, B. Caughey, Y. Compta (Barcelona, Spain)

    Objective: To investigate whether 4R-TAU seed amplification assay discriminates tauopathies from non-tauopathies as well as CBD from PSP in post-mortem brain samples. Background: 4 repeat…
  • 2025 International Congress

    Neurogenic bladder and affective disorders in parkinsonism

    E. Korshunova, M. Khommyatov, M. Samushiya, N. Suponeva (Moscow, Russian Federation)

    Objective: To determine the relationship between psychoemotional and dysuria dysfunctions in patients with PD and MSA. Background: In the group of patients with extrapyramidal pathology…
  • 2025 International Congress

    Unraveling Functional Overlay in Parkinson’s Disease: A Diagnostic Challenge

    RAM. Carandang, P. Panyakeaw (Bangkok, Thailand)

    Objective: To highlight the diagnostic complexities of functional movement disorders (FMD) in Parkinson’s disease (PD) and the role of neurophysiological studies in differentiating functional overlay…
  • 2025 International Congress

    The Impact of Levodopa on Gait in Parkinson’s Disease: A Quantitative Analysis of Striatal Dopamine Transporter Availability and Lateralization

    YS. Kim, DG. Park, JH. Yoon (Suwon, Republic of Korea)

    Objective: This study aimed to analyze gait changes in Parkinson’s disease (PD) patients before and after levodopa administration, examining correlations between gait parameters and striatal…
  • 2025 International Congress

    Prodromal Lewy body dementia features in isolated REM sleep behavior disorder with neuronal synuclein disease

    D. Weintraub (Philadelphia, USA)

    Objective: To assess for cognitive impairment and features of prodromal Lewy body dementia (LBD) in persons with isolated REM sleep behavior disorder (iRBD) and neuronal…
  • 2025 International Congress

    How Feasible and Valuable is Home Lying Standing Blood Pressure Monitoring in People with Parkinsonism?

    K. Lloyd, S. Haworth, M. Nogradi, C. Glover, EJ. Henderson (Bristol, United Kingdom)

    Objective: To evaluate the feasibility and value of home lying-standing blood pressure monitoring in the detection of orthostatic hypotension (OH) in people with parkinsonism (PwP).…
  • 2025 International Congress

    Unveiling Parkinson’s Disease Variants in the Chinese Population: The CPD10KGP Study

    Y. Zhao, Z. Liu, H. Pan, J. Guo, B. Tang (Changsha, China)

    Objective: In response to these limitations, we are proposing the China Parkinson’s Disease 10,000 Genomes Project (CPD10KGP), which aims to delineate the genetic architecture of…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley